STAAR Surgical Co
Suletud
SektorTervishoid
28.35 -1.29
Ülevaade
Aktsiahinna muutus
24h
Min
28.16
Max
28.47
Sissetulek | 5.2M 5.2M |
|---|---|
Müük | 36M 94M |
Aktsiakasum | 0.1 |
Kasumimarginaal | 5.567 |
Töötajad | 921 |
EBITDA | 28M 20M |
Soovitused | Neutraalne |
|---|---|
12 kuu keskmine prognoos | +10.43% upside |
Järgmine tulemuste avaldamine | 5. aug 2026 |
|---|
Turukapital | 106M 1.5B |
|---|---|
Eelmine avamishind | 29.64 |
Eelmine sulgemishind | 28.35 |
Uudiste sentiment
By Acuity
38%
62%
102 / 342 Pingereas Healthcare
STAAR Surgical Co Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.